AKT1 and metabolic dysfunction-associated steatotic liver disease: IR is characterized by the subdued activation of the proximal insulin signaling cascade, particularly Akt, which in turn leads to deregulation of downstream targets, like GSK3, PRAS40, Foxo1, and, consequently, the inability to downregulate gluconeogenesis during NAFLD.